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Abstract
The non–lipid-dependent yeastMalassezia pachydermatis is predominantly zoophilic but
occasionally colonizes the human skin. This yeast caused an outbreak in a neonatal iIn-
tensive care unit (NICU). This study aimed to describe the molecular epidemiology of
this M. pachydermatis outbreak. All the M. pachydermatis isolates collected at a French
University Hospital from January 2012 to April 2013 were included in the study. M.
pachydermatis isolates, sampled from various biological samples sites in 25 patients,
were identified via MALDI-TOF mass spectrometry and typed using intergenic-spacer 1
(IGS1) nucleotide sequence polymorphisms analysis. By analyzing 90 IGS1 sequences
(including 43 deposited in GenBank), we found that of the 186 M. pachydermatis iso-
lates, 47 were viable for typing and all of them clustered within type 3; 78.7% clustered
within the 3D subtype; the remaining clusteredwithin three newly described subtypes: 3E
(4.3%), 3F (8.5%) and 3 G (8.5%). No particular subtype was associated with a collection
site or a particular time period. This first molecular investigation of a M. pachydermatis
outbreak in neonates showed that multiple genotypes can colonize the same neonate
patient by. The source of this polyclonal outbreak could not be identified. It stopped after
infection control measures, including the prohibition of a lipid-rich moisturizing hand
cream used by the health care staff, had been implemented.
Key words:Malassezia pachydermatis, neonates, outbreak, typing, IGS1.
Introduction
The lipophilic yeast M. pachydermatis belongs to the resi-
dent skin flora of many animal species and is commonly
isolated from the skin and mucus membranes of dogs.
Yeasts overgrowth on the skin could be promoted by ex-
cessive sebum production and/or disruption of epidermal
C©TheAuthor 2017. Published byOxfordUniversity Press onbehalf of The International Society for HumanandAnimalMycology.
All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
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barrier, which may occur in hypersensitivity diseases;
keratinization disorders; infections, including ectopara-
sitic diseases; and endocrine disorders.1,2 Whereas M.
pachydermatis is the only primarily zoophilic species in the
genus Malassezia, it occasionally colonizes the human skin
and has also been isolated from various human biologi-
cal samples (sputum, bronchial alveolar lavage, peritoneal
fluid, etc.).2,3 M. pachydermatis also causes blood-stream
infection, especially in neonates, in whom this yeast has
been involved in health-care associated outbreaks.2,4,5 Sev-
eral studies have stressed the importance of molecular typ-
ing to understand the clonal nature, the transmission routes
and spreading mechanism of a fungus involved in an out-
break.6 The genetic diversity of M. pachydermatis strains
obtained from animals has been highlighted by analyzing
the nucleotide sequences of the D2 variable region of the
26S rRNA gene and the chitin synthase 2 (CHS2) gene.2,7,8
More recently, Sugita el al. identified three major types (1,
2, and 3) in M. pachydermatis isolated from dogs and cats,
which were further separated into 10 subtypes (1A, 1B, 1C,
1D, 2A, 2B, 3A, 3B, 3C, and 3D, as detailed in Table 1)
by using the 18S-26S rRNA intergenic spacer (IGS) 1 re-
gion.9 The present study aimed to describe the molecular
epidemiology of M. pachydermatis outbreak that occurred
in a neonatal intensive care unit (NICU).
Methods
Patients and samples
From January 10 2012, date to diagnosis of the first M.
pachydermatis fungemia, to February 2013, all infants with
a birth weight lower than 3,100 gr hospitalized at the NICU
of the University Hospital of Amiens (France) were sys-
tematically screened for the presence of M. pachydermatis
colonization. A total of 390 samples were analyzed: 12
stools, 103 nasal, 108 axilla, 106 anal, 21 blood, 4 skin,
24 urine, and 12 respiratory samples. Additionally, for the
purpose of outbreak investigation, two nasal swabs, two ear
swabs, and one interdigital spaces swab were collected from
710 healthcare workers, including 120 electro-radiology
manipulators and electro-physiologists, 110 physiothera-
pists, 330 nurses and nursery nurses, 45 assistants, and
105 medical doctors. We also collected 60 environmen-
tal samples, including: 37 electronic equipment (cardiac
monitoring systems, mixers, phone, ultrasound probes, etc.)
and 23 baby incubators. All samples were inoculated onto
both Sabouraud dextrose (Bio Rad, Marne la Coquette,
France)10,11 and Chromagar Candida (Becton Dickinson,
Le Pont de Claix, France) medium plates and incubated at
32◦C for 7 days. A patient was considered colonized with
M. pachydermatis if this yeast was cultured from at least
one of his samples. Neither Dixon’s nor Leeming-Notman
medium were available at the hospital’s laboratory. There-
fore, only M. pachydermatis and no other Malassezia spp
could be isolated. Yet this approach adequately addressed
the investigation of the M. pachydermatis blood stream in-
fections outbreak.
M. pachydermatis identification
Isolated yeast colonies were identified according to their
macroscopic and microscopic features. The macroscopic
features of the predominant colonies included their shape,
size, color, consistency, and the characteristics of surround-
ing culture medium. Microscopic features of the yeast cells
in culture were described after lactophenol staining and
included the predominant morphology, size, and budding
base of the yeasts at 1000X magnification. The strains were
kept at −80◦C. BothMALDI-TOFmass spectrometry iden-
tification and typing was performed at the Parasitology and
Mycology laboratory of Marseille’s University Hospital La
Timone in October 2014.
MALDI-TOF mass spectrometry identification
The isolates were subcultured on Sabouraud’s medium and
incubated for 3–7 days at 32◦C. MALDI-TOF mass spec-
trometry identification of the M. pachydermatis isolates
was performed with a Microflex LTTM (Bruker Daltonics,
Germany) instrument, by comparing the isolate’s spec-
tra to an in-house reference spectra library that included
Malassezia spp. reference spectra via the MALDI Biotyper
v3.0 (Bruker Daltonics) software, as previously described.12
M. pachydermatis molecular typing
IGS1 typing was performed on the 47 M. pachydermatis
isolates that had been collected from 24 children and one
adult, as detailed in Table 2. DNA was extracted from a
colony suspension in 800 μl of lysis buffer (bioMe´rieux,
Craponne, France) using a NucliSENSTM easyMAGTM V2
(bioMe´rieux) following the manufacturer’s instructions,
and eluted in 50 μl H2O. The IGS1 domain from the
rRNA gene was amplified using the previously described
PCR conditions and the primer set designed by Sugita
et al.: 26S-F (5′-ATCCTTTGCAGACGACTTGA-3′) and
Mala-R (5′-TGCTTAACTTCGCAGATCGG-3′).13 Thirty-
five cycles of PCR amplification were performed under
the following conditions: denaturation for 30 s at 95◦C,
primer annealing for 30 s at 58◦C and polymerization
for 1 min at 72◦C in a total reaction volume of 20 μl of
an amplification mixture consisting of 10 mM Tris-HCl
(pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.001% gelatin,
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Table 1. IGS1 genotype-based Sugita groups and their accession numbers.
Accession no. Source Country IGS1 Type Base pair
AB118940 Dog, otitis externa Hungary 2A 759
AB118596 Dog, otitis externa Hungary 2A 759
AB118597 Dog, otitis externa Hungary 3C 861
AB118598 Dog, otitis externa Hungary 2A 759
AB118599 Dog, otitis externa Hungary 2A 759
AB118600 Dog, otitis externa Hungary 1C 591
AB118601 Dog, ear of healthy subject Hungary 1D 601
AB118602 Dog, otitis externa Hungary 1B 567
AB118603 Dog, ear Hungary 1C 591
AB118604 Dog, otitis externa Hungary 3D 898
AB118605 Dog, ear Hungary 3D 898
AB118606 Dog, otitis externa Hungary 2B 761
AB118607 Dog, ear Hungary 1A 552
AB118608 Dog, ear Hungary A1 552
AB118609 Dog, chronic otitis externa Hungary 2A 759
AB118610 Dog, chronic otitis externa Hungary 2A 759
AB118611 Dog, dermatomycosis Slovakia 3D 898
AB118612 Dog, otitis externa Slovakia 3D 898
AB118613 Dog, otitis externa Slovakia 3D 898
AB118614 Dog, dermatomycosis Slovakia 3D 898
AB118615 Cat, dermatomycosis Slovakia 3B 859
AB118616 Dog, dermatomycosis Slovakia 3D 898
AB118617 Dog, vagina Slovakia 3D 898
AB118618 Dog, dermatomycosis Slovakia 2B 761
AB118619 Dog, dermatomycosis Slovakia 3D 898
AB118620 Dog, otitis externa Slovakia 3D 898
AB118621 Dog, otitis externa Slovakia 3D 898
AB118622 Dog, seborrhoeic dermatis Slovakia 3A 749
AB118775 Dog, femur of healthy subject Japan 2B 761
AB118776 Dog, externa of healthy subject Japan 1A 552
AB118777 Dog, externa of healthy subject Japan 1A 552
AB118778 Dog, externa of healthy subject Japan 1A 552
AB118779 Dog, umbilical area of healthy subject Japan 1A 552
AB118780 Dog, femur of healthy subject Japan 1A 552
AB118781 Dog, externa of healthy subject Japan 1A 552
AB118782 Dog, externa of healthy subject Japan 1A 552
AB118783 Dog, externa of healthy subject Japan 2A 759
AB118784 Dog, dorsal area of healthy subject Japan 2A 759
AB118785 Dog, externa of healthy subject Japan 3D 898
AB118786 Dog, externa of healthy subject Japan 1A 552
AB118787 Dog, externa of healthy subject Japan 1A 552
AB118788 Dog, externa of healthy subject Japan 1A 552
AB118941 Dog, otitis externa Sweden 3D 898
2.5 mM of each deoxynucleotide triphosphate, 1 U Taq
polymerase, and 0.5 μg of each primer. Amplicons were
visualized after ethidium bromide staining of agarose gel
electrophoresis and purified with the UltraClean GelSpin
DNA Purification Kit (MO BIO Laboratories, Inc., CA,
USA) according to the manufacturer’s recommendations.
Both strands were sequenced using the BigDye Ter-
minator Cycle Sequencing Ready Reaction kit version
3.1 (Applied Biosystems, France), the primers Mala F
(5′-TCTTCCTTGTCCTCTGACTT-3′), IGS1 R (5′-
GTATGTTATGCTGTGCTGTG-3′), M.pach-IGS1F (5′-
TCCAGCCACGCTCCACACGA-3′), and M.pach-IGS1R
(5′-TCGTGTGGAGCGTGGCTGGA-3′). Sequence reac-
tion products were purified using the BigDye XTerminator
Purification Kit (Applied Biosystems) and analyzed with
an ABI 3130 Genetic Analyzer (Applied Biosystems).
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Table 2. Origin and IGS1 typing results of the Malassezia pachydermatis strains involved in the neonatal intensive care unit.
IGS 1
Sex, Age Sample Collection Length GenBank
Patient (days) ID date Site Type (base pairs) accession no.
P1 M, 15 MP1 27/03/2013 nasal 3D 895 KP639639
MP2 27/03/2013 urine 3F 894 KP639680
MP3 27/03/2013 axilla 3D 903 KP639640
P2 M, 12 MP4 10/04/2013 anal 3D 894 KP639656
P3 F, 22 MP5 06/03/2013 skin 3D 895 KP639666
MP6 06/03/2013 axilla 3D 894 KP639665
MP7 06/03/2013 nasal 3D 896 KP639664
MP8 06/03/2013 stools 3D 895 KP639663
MP9 21/02/2013 axilla 3D 894 KP639662
MP10 21/02/2013 nasal 3D 897 KP639661
P4 F, 60 MP11 13/03/2013 axilla 3D 897 KP639667
MP12 13/03/2013 urine 3D 898 KP639668
MP13 10/02/2013 nasal 3D 896 KP639669
P5 M, 32 MP14 25/03/2013 anal 3D 900 KP639660
P6 F, 59 MP15 03/01/2013 nasal 3D 895 KP639673
P7 M, 21 MP16 09/08/2012 axilla 3F 894 KP639682
P8 F, 22 MP17 31/07/2012 axilla 3F 894 KP639681
MP18 31/07/2012 anal 3F 894 KP639683
MP19 25/07/2012 urine 3D 894 KP639674
P9 F, 23 MP20 28/07/2012 axilla 3G 894 KP639678
P10 F, 37 MP21 12/05/2012 axilla 3D 898 KP639675
MP22 12/05/2012 skin 3D 897 KP639641
P11 F, 19 MP23 12/05/2012 anal 3E 894 KP639684
MP24 12/05/2012 stools 3D 894 KP639642
P12 F, 11 MP25 25/05/2012 urine 3D 902 KP639643
P13 M, 15 MP26 28/06/2012 axilla 3D 896 KP639644
P14 F, 37 MP 27 21/02/2012 stools 3D 894 KP639645
MP28 21/02/2012 axilla 3G 895 KP639676
MP29 21/02/2012 axilla 3D 898 KP639652
MP30 21/02/2012 blood 3D 895 KP639653
MP31 21/02/2012 anal 3D 902 KP639651
P15 F, 8 MP32 16/04/2012 axilla 3D 891 KP639646
P16 M, 3 MP33 13/04/2012 axilla 3D 899 KP639647
P17 M, 19 MP34 19/04/2012 nasal 3D 895 KP639670
MP35 19/04/2012 urine 3D 895 KP639672
MP36 19/04/2012 axilla 3E 894 KP639685
MP37 19/04/2012 nasal 3D 895 KP639671
P18 M, 21 MP38 05/04/2012 skin 3D 895 KP639648
P19 M, 27 MP39 22/03/2012 axilla 3D 896 KP639649
MP40 22/03/2012 nasal 3D 897 KP639650
P20 F, 19 MP41 21/02/2012 nasal 3D 891 KP639654
MP42 21/02/2012 anal 3G 894 KP639677
P21 M, 49 MP43 13/04/2012 nasal 3D 899 KP639655
P22 M, 25 MP44 13/04/2012 nasal 3D 894 KP639657
P23∗ M, 33 years MP45 16/11/2011 skin 3D 897 KP639658
P24 M, 18 MP46 12/01/2012 nasal 3G 894 KP639679
P25 M, 63 MP47 21/02/2012 anal 3D 900 KP639659
ID, identification; NICU, neonatal intensive care unit.
∗This strain, isolated from an adult kidney transplant recipient patient hospitalized in the same hospital, but in a ward distant to the NICU.
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Sequences were assembled, edited, and manually cor-
rected using Sequencher (v. 4.1.4). The IGS1 sequences
types of our isolates was determined by comparing their
sequences with those deposited in the NCBI GenBank
nucleotide database, which were collected from healthy
or skin diseased dogs and cats, as described in,9 which
are described in Table 1. These IGS1 M. pachydermatis
nucleotide sequences were aligned using the multiple
sequence alignment program ClustalW 1.8 included in the
Molecular Evolutionary Genetics Analysis (MEGA) v. 4.1
software. An UPGMA dendrogram was generated with
1000 bootstrap replications using MEGA.14 A phenogram
using a Minimum Spanning Tree (MST) graphing algo-
rithm was generated using SplitTree software.15 Using as
the priority rule for MST construction the classification of
M. pachydermatis genotypes into different groups.
Statistical analyses
Statistical analyses were performed using IBM SPSS soft-
ware (v. 20.0; IBM SPSS Inc., New York, USA). The Chi-
square test was used. A P value > .05 was considered
significant.
Results
Epidemiological survey
Sixty-four infants were admitted to the NICU during the
M. pachydermatis outbreak period (January 2012 to April
2013). A blood-stream infection was diagnosed in two pa-
tients, on February 2 and September 28, 2012, respectively.
From January 2012 to April 2013, 390 biological sam-
ples, including 12 stools, 103 nasal, 108 axilla, 106 anal,
21 blood, 24 urine, 4 unspecified cutaneous, and 12 respira-
tory samples were analyzed. M. pachydermatis was grown
in 186 (47.7%) of the samples collected from 60 of 64
(93.8%) neonates. The prevalence of M. pachydermatis
colonization, in infants was 93.8%. The infants colonized
by M. pachydermatis were born at a mean of 29.1 (±3.1)
weeks of amenorrhea; their mean birth weight was 1353.2
(±765.8) gr. M. pachydermatis was isolated in 54 (89%)
of the 61 infants with a central venous catheter and in 49
(86%) of the 57 on parenteral nutrition. M. pachyderma-
tis positive culture occurred throughout the outbreak; there
was no notable time cluster.
No M. pachydermatis culture was positive in the 710
health-care worker samples and 60 samples from the NICU
environment collected from January 2012 to April 2013.
Control interventions
To address this M. pachydermatis outbreak and to prevent
further systemic infection cases the following interventions
were implemented: (i) the colonized or infected neonates
were treated with 3 mg or 6 mg /kg /d of fluconazole, re-
spectively; (ii) hand hygiene and no jewelry rule for the
medical and nursing staff was strengthened; (iii) local and
environmental cleaning was strengthened; and (iv) the use
of lipid-rich fatty creams or gels was strongly discouraged.
Molecular typing results
Seventy-six of the 186 M. pachydermatis isolates, collected
from 24 children and one adult, had been kept. IGS1 re-
gion nucleotide sequencing was successful in 47 (62%) of
these 76 isolates. Failure occurred because some isolates
could not be cultured. The characteristics of the 47 M.
pachydermatis species IGS1 sequences and their respective
GenBank accession numbers are detailed in Table 2. They
had been collected from various biological samples, includ-
ing skin (4), nose (12), anal (7), axilla (15), urine (5), stool
(3), and blood (1) of 24 children at the NICU; one iso-
late was collected from an adult patient hospitalized at the
kidney transplant unit.
The joint analysis of the 47 IGS1 sequences from our
study and the 43 sequences of Sugita et al.9 (a total of
90 IGS1 sequences) highlighted that all of our 47 M.
pachydermatis isolates clustered within Type 3 (Fig. 1).
Figure 2 shows the characteristic IGS1 sequence features
of each M. pachydermatis Type 3 subtypes. Noteworthy,
our findings allowed describing than M. pachydermatis
IGS1 subtype of isolates obtained from different samples of
neonate patients were: 3D (78.7%), 3E (4.3%), 3F (8.5%),
and 3 G (8.5%), with the appearance of three new subtypes
in type 3 (Table 2): two isolates classified in subtype 3E, 4
isolated classified in subtype 3F and four isolated in subtype
3 G, as illustrated in Figure 3. No particular subtype was
associated with any collection site or particular time period.
Subtype 3D was isolated from patients at the NICU and
in one adult kidney transplant recipient (Table 2). The two
newly described subtypes, 3F and 3E, were only isolated
from patients at the NICU. Whereas six patients were colo-
nized by multipleM. pachydermatis genotypes, the 19 other
patients were colonized by a single genotype.
Discussion
The non–lipid-dependent M. pachydermatis species in-
volved in the present outbreak has the particularity to
preferentially colonize and cause diseases in animals,
whereas lipid-dependent species, such as M. globosa, M.
sympodialis, M. furfur, and M. restricta, colonize the skin
and are common human superficial mycoses agents. 16–20
Hence, reports of human systemic infections due to M.
pachydermatis are scarce.10,21 SevereM. pachydermatis in-
fections have infrequently been reported in adults,2,21–23
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Figure 1. A Minimum Spanning Tree based on the IGS 1 sequences of 90 M. pachydermatis isolates: 47 were collected in this outbreak investigation
and 43 had been deposited by Sugita et al. [9]. S, sequences from Sugita et al.; S1A, Group 1 subtype A1; S1B, Group 1 subtype B1; S1C, Group 1
subtype C1; S1D, Group 1 subtype D1; S2A, Group 2 subtype A2; S2B, Group 2 subtype B2; S3A, Group 3 subtype A3; S3B, Group 3 subtype B3; S3C,
Group 3 subtype C3; S3D, Group 3 subtype D3; MP, sequences from this study’s isolates.
and in most cases systemicM. pachydermatis infections oc-
curred in hospitalized neonates. Four studies investigated
the epidemiology ofM. pachydermatis in neonates.4,21,24,25
Welbel et al. investigated a hospital-acquired bloodstream
infections outbreak due to M. pachydermatis in premature
infants and highlighted that parenteral nutrition and/or in-
travenous lipid infusion were the major risk factor of M.
pachydermatis infection and that person to person, proba-
bly via the caregiver’s hands was the most likely transmis-
sion route.2,4,26 These authors hypothesized thatM. pachy-
dermatis patient’s colonization was acquired following con-
tact with the parents or the nursing staff. Systemic infection
route was traced to subsequent intravenous catheters colo-
nization in neonates whose skin was colonized byM. pachy-
dermatis. Several studies highlighted that the prolonged use
of indwelling catheters and parenteral lipid emulsions have
been as key risk factors for M. pachydermatis infection
and additionally Malassezia species have also been found
to survive for long periods on the surfaces of baby incu-
bators.25,27 Although this had not been quantified in our
study, empirical observation suggested that M. pachyder-
matis colonization increased in the members of the medical
staff who use hand creams. One limitation of our epidemi-
ological investigation was thatM. pachydermatis could not
be cultured from the numerous health-care worker samples
that had been collected in this study.One explanation of this
finding might be that the dates of the sampling campaigns
had been notified before to the staff, which might have
induced systematic stringent hand disinfection or cleaning
practices before.
Recently, Al-Sweih et al. described a case of M.
pachydermatis fungemia in a preterm neonate, where the
isolate was identified via rRNA nucleotide sequence anal-
ysis of the ITS and D1/D2 regions.28 We identified via
MALDI-TOF mass spectrometry and IGS1 nucleotide se-
quence analysis the M. pachydermatis isolates collected
from different body sites in neonate infants. MALDI-TOF
mass spectrometry is rapid, simple, and accurate, pro-
vided that a comprehensive reference spectra database is
used.2,29,30 The nucleotide sequence of the IGS1 region that
we used for typing is a highly polymorphic region within
M. pachydermatis genome; it is greater than 400 bp long
and share approximately 40 to 50% similarity among M.
pachydermatis isolates. In contrast, the IGS1 region is ap-
proximately 70 bp long and share more than 85% similar-
ity within the other species in the genus.31,32 It thus can
be used for nucleotide sequence-based identification of M.
pachydermatis but not of the other Malassezia species.
In the present study, following Sugita’s IGS1 isotype clas-
sification,9 we identified three new isotypes (3E, 3F, 3 G)
within group 3. We demonstrated that isolates of subtype
3D were frequently (78.7%) isolated in this French NICU
patients’ population. In dogs, the most prevalent isolates
from skin lesions of atopic dermatitis also belong to subtype
3D in Japan and Taiwan but more frequently to subtype
3C in Korea.33 In line with Kobayashi et al., who reported
no significant association between the IGS1 genotype and
disease presentation or colonization site,31 we found no as-
sociation between any particular subtype with collection
site or a particular time period. Noteworthy, our findings
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Figure 2. Alignment of theMalassezia pachydermatis IGS1 sequence of subtypes 3A to 3 G. Asterisks (∗) are used when the nucleotide at a particular
position is identical in all groups. Dashes ( ) represent alignment gaps.
highlighted that neonates might be colonized by multiple
genotypes.
The results of the present study indicate that patients
were colonized by multiple M. pachydermatis genotypes.
Probably, patient’s colonization was acquired after diverse
contact with the nursing staff. However, one limitation of
our study was that only 25% (47/186) of the isolates col-
lected from 40% (24/60) of colonized neonates could ulti-
mately be typed.
In conclusion, the rRNA gene IGS1 region typing proved
simple and effective in investigating the present NICU M.
pachydermatis outbreak. Whereas we described three novel
ofM. pachydermatis subtypes, the subtype 3Dwas the most
frequent in this French low-birth weight neonate popula-
tion. Typing highlighted the polyclonal nature of this M.
pachydermatis outbreak that ended after the implementa-
tion of several control measures including strengthening
hygiene and restricting the use of lipid-rich fatty creams or
gels by the medical and nursing staff.
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Figure 3. Phylogenetic tree of the 47 IGS1 sequences of the Malassezia
pachydermatis strains isolated in this outbreak investigation.
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